Financial research concept

North American Pharmaceutical Operating Margin

North American Pharmaceutical operating margin measures McKesson's segment operating profit relative to revenue in its large-scale pharmaceutical distribution business.

By Lee BaileyPublished Sep 24, 2026
Research context

See what supports this page, how current it is, and where comparable or historical context is available.

Research date
Sep 24, 2026Use the dated article and cited sources for the definition, examples, and stated limitations.
Operating-model context
15 connected conceptsPart of the reviewed Healthcare Distribution & Services Economics; issuer definitions remain distinct where disclosed.
Company examples
1 reviewed companyRelationships reflect supported examples, not a normalized cross-company KPI ranking.
  1. How to read it
  2. Comparison caution
  3. Part of the Healthcare Distribution & Services Economics
  4. See It in Company Research
  5. Continue Research

north american pharmaceutical operating margin is McKesson's reported segment operating profit margin for North American Pharmaceutical. McKesson reported a fiscal 2026 North American Pharmaceutical segment operating profit margin of 1.09%, up from 0.97% in fiscal 2025.

How to read it

The margin relates segment operating profit to segment revenue on McKesson's stated segment basis. Because the company's business lines range from very high-volume pharmaceutical distribution to more service-heavy activities, absolute margin levels can differ sharply even inside the same company.

Comparison caution

This is an issuer-defined segment margin, not a standardized healthcare-distribution margin and not consolidated GAAP operating margin. Segment composition, LIFO effects, acquisitions, litigation or settlement items, and the split between product and service revenue can change the measure. A higher margin should be interpreted with its revenue base and business mix rather than as a standalone quality score.

Primary source: McKesson fiscal 2026 Form 10-K.

Part of the Healthcare Distribution & Services Economics

Connect pharmaceutical and medical distribution scale, specialty and prescription-technology profitability, service mix, and asset intensity to understand healthcare distribution and services economics.

How the model fits together
  • Core pharmaceutical distribution scale and margin: North American Pharmaceutical revenue shows the scale of McKesson's core distribution engine, while segment operating profit and margin show how a very large revenue base converts into segment earnings. Service revenue mix helps preserve the distinction between product-heavy distribution revenue and service-oriented economics.
  • Specialty care and prescription-technology economics: Oncology & Multispecialty and Prescription Technology Solutions pair revenue scale with segment profit and margin across specialty distribution, provider solutions, medication-access technology, and third-party logistics. Service revenue mix adds context for why these businesses can carry different economics without implying standardized peer margins.
  • Medical-surgical distribution and asset intensity: Medical-Surgical Solutions revenue, operating profit, and margin show the economics of non-acute distribution, while segment depreciation and amortization and long-lived-asset expenditures show different views of the asset base and current investment. Those capital measures are not interchangeable with each other or with total company capital expenditure.

See It in Company Research

These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.

Continue Research

Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.

Compare stocks

Compare healthcare distribution and services stocks

Continue into stock comparison after reviewing segment scale, profitability, service mix, and capital intensity across healthcare distribution and services businesses.

Continue research

Explore more topics in the Financial Research Encyclopedia.